Stockreport

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial [Yahoo! Finance]

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF Phase 1 ELIMINATE-B trial for PBGENE-HBV is progressing and on track to report additional data from higher dose cohorts in 2025 - DURHAM, N.C., October 07, 2025 BUSIN [Read more]